Look for any podcast host, guest or anyone
Showing episodes and shows of

WCG

Shows

WCG Talks TrialsWCG Talks TrialsFuture-Ready Research: Optimizing Sites for Continued SuccessIn this episode of WCG Talks Trials, Sandy Smith, senior vice president, clinical solutions & strategic partnering, WCG, is joined by Tiffany Pierce, director, clinical trials core, Henry Ford Health System, to discuss resilience in clinical research.As the landscape of clinical trials faces evolving challenges, they explore how organizations and institutions, like Henry Ford Health, are addressing disruptions, uncertainties, and changes at the federal level. Learn about innovative strategies to enhance trial efficiency, including role clarity, flexible workflows, and diversifying research portfolios.With a focus on maintaining forward momentum in trials and remaining nimble, they...2025-06-2020 minWCG Talks TrialsWCG Talks TrialsHarnessing Generative AI in Clinical ResearchDive into the world of generative AI with Silvio Galea, chief data analytics officer, WCG, and Kyle Miller, lead data scientist, WCG. In this compelling episode of WCG Talks Trials, we explore how Generative AI can improve clinical research workflows from meticulous data entry to efficient data validation. Uncover the technology behind AI’s ability to assist in document updates, highlight transcription biases, and digitize complex data for predictive analytics. Understand the importance of human oversight and practical applications that can optimize how clinical trials are conducted. Whether you’re curious about AI’s role in reading dense documents or lev...2025-05-2823 minWCG Talks TrialsWCG Talks TrialsAI in Clinical Trials: Unlocking the PotentialIn this episode of WCG Talks Trials, join Silvio Galea, chief data and analytics officer, WCG, and Melissa Hutchens, vice president of research and benchmarking, WCG, as they discuss the transformative role of AI in clinical trials. Discover how generative AI and other AI technologies are enhancing the quality of clinical trials, reducing cycle times, and cutting costs. The episode covers the benefits, barriers, and concerns associated with AI, and explores its applications in drug discovery, participant recruitment, trial design, and more. Tune in to learn about the latest advancements in AI and how they are shaping the future...2025-03-1827 minWCG Talks TrialsWCG Talks TrialsBreaking Down Site Complexities and Start-Up Barriers in Clinical TrialsJoin us for "Breaking Down Site Complexities and Start-Up Barriers in Clinical Trials" as we uncover the complexities of site management and the barriers to effective study start-ups. Discover the top issues impacting research sites and strategies to overcome them, including trial complexity, start-up hurdles, and long initiation timelines.  Learn how effective communication, teamwork, and clear processes can drive success, and the importance of human connections and inclusivity in clinical research. Get practical advice for improving site readiness and trial efficiency from our expert guests.  Don't miss this essential episode on navigating the evolving clinical tr...2025-02-2425 minThe Bull of Wall StreetThe Bull of Wall Street#9 - Paisley Nardini, MD with Simplify, Jim Worden, CIO WCG, Talley Léger, CMS WCG (recorded 01/23/25)This interview is with our own investment strategy committee leaders Jim Worden, CFA, CAIA, and CIO, Talley Léger, Chief Market Strategist, and Paisley Nardini, CFA, CAIA. We talk about their background, WCG’s investment process, markets, and working with advisors. We highlight working with outside consultants so we can incorporate the best of the best into our process. 2025-01-241h 03WCG Talks TrialsWCG Talks TrialsFrom Patient Care to Discovery: A Clinician's Journey into ResearchJoin us for a compelling episode of WCG Talks Trials where we take a look into the rewarding world of clinical trials and clinical development. In this episode, George Cokenakes, director of clinical services, review solutions, WCG, speaks with Dr. James Januzzi, a renowned cardiologist at Massachusetts General Hospital, and chief scientific officer at Baim Institute for Clinical Research. Dr. Januzzi shares his inspiring journey, highlighting the significance of clinical trial participation and the diverse opportunities that can shape a medical career. Learn from Dr. Januzzi's extensive experience in clinical research, including his work on cardiac biomarkers, d...2024-12-1019 minWCG Talks TrialsWCG Talks TrialsInside MAGI: Innovation, Education, and Industry TrendsIn this episode of "WCG Talks Trials," host Geoffrey Schick, director of strategic site partnerships, WCG, is joined by fellow MAGI@home 2024 speakers Sandy Smith, Jess Thompson, and Wesley Warren. They share their unique perspectives and key takeaways from this year's virtual conference, including discussions on contract negotiations, the evolving role of advanced practice practitioners, and the collaborative panels featuring both site and sponsor/CRO insights. The episode also recaps the impactful session on the FDA's Diversity Action Plan and what it means for the future of clinical trials. Tune in to hear about the dynamic energy, valuable connections...2024-11-2529 minWCG Talks TrialsWCG Talks TrialsRevolutionizing Clinical Research Through Collaboration and InnovationIn this episode of WCG Talks Trials, host Sandy Smith, senior vice president of clinical solutions and strategic partnering at WCG, dives into the highlights of the Florence Healthcare Research Revolution event. Sandy is joined by industry experts Andrea Bastek, vice president of innovation at Florence, and Lauren Sobocinski, senior vice president of strategic alliances at WCG, to discuss transformative insights from the event. Discover the latest trends shaping clinical research, including site engagement, protocol complexity, and effective sponsor-site relationships. Tune in for a compelling discussion on how collaborative efforts and innovative technologies are driving positive change in the...2024-11-0728 minWCG Talks TrialsWCG Talks TrialsHave a Safe Trip: Clinical and Patient Alignment in Research with PsychedelicsIn this episode of WCG Talks Trials, host Kelly FitzGerald sits down with Dr. Currien MacDonald, Medical Chair Director at WCG, and Sara Reed, a participant in two psychedelic clinical trials, to explore the evolving landscape of psychedelics research. Dr. MacDonald shares his expertise on the growing acceptance of psychedelics in clinical settings, recent FDA updates, and the inner workings of ongoing trials. Later, Sara provides a firsthand account of her experiences as a trial participant, offering unique insights into how psychedelics are being tested as potential therapeutic options. Tune in to learn more about aligning clinical practice with...2024-10-0723 minWCG Talks TrialsWCG Talks TrialsBreaking Barriers: Reasons to Expand Site Cancer Trial PortfoliosIn this episode of WCG Talks Trials, Geoff Schick, director of strategic site partnerships, joins our host Sandy Smith, senior vice president of clinical solutions and strategic partnering, to discuss the expansion of research site cancer portfolios.2024-09-1828 minWCG Talks TrialsWCG Talks TrialsPatient Advocacy Advancing Breakthrough Science and Community EngagementJoin Desiree Underwood-Williams, director of project management organization at WCG and guest Steve Smith, CEO of SteveSmithPlans LLC and facilitator of the WCG Patient Forum, as they recap the latest Patient Forum Focus Session on breakthrough science and community engagement. Discussion highlights include:The impact of medical diagnoses on families with Sickle cell disease and melanoma.New research in cell and gene therapy that’s directly impacting Sickle cell  disease and melanoma patients.New diversity laws shaping the future of drug development.Community engagement and how patients can get involved in their care.And more insights into the WCG...2024-09-1628 minWCG Talks TrialsWCG Talks TrialsGuarding Research Integrity: The IRB's Essential Role In this episode of WCG Talks Trials, we are joined by host Joanne Thomas, clinical reviewer and patient advocate at WCG, along with our guest Currien MacDonald, medical chair director at WCG. This episode covers the roles of IRB in ethical clinical research, frequently asked questions, and a general overview of the IRB’s role in clinical trials.2024-09-1327 minWCG Talks TrialsWCG Talks TrialsAddressing Challenges in Site FeasibilityThis episode of WCG Talks Trials addresses site feasibility challenges impacting the clinical trials industry. Join Michelle Yu, associate director of clinical strategy at WCG, and our guest Trevor Cole, director of client delivery, site and strategic operations for WCG, as we discuss approaches to adopt innovative feasibility and site start-up solutions.Here are links to documents referenced in this episode:Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research StatementMain Article: https://ascopubs.org/doi/10.1200/OP.20.00821  PDF Data Supplement: https://society.asco.org/sites/new-www.asco.org/f...2024-08-3020 minWCG Talks TrialsWCG Talks TrialsEthical Review and AI in Clinical TrialsJoin our Chief Analytics Officer Silvio Galea, along with Dr. Donna Snyder & Dr. Barbara Bierer to discuss opportunities on the ethical and regulatory challenges regarding artificial intelligence in clinical trials. The discussion is focused through the lens of the IRB review, and how a multi-stakeholder task force led by the Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and WCG will address the growing need for guidance in this rapidly evolving area of research.2024-06-2139 minWCG Talks TrialsWCG Talks TrialsAddressing Measurement Challenges for PTSD Trials with TechnologyIn this episode of WCG Talks Trials, we are joined by WCG clinical science experts as they discuss traditional measurement challenges for PTSD trials and how the use of an electronic CAPS-5 scale is improving administration and scoring errors. Tune in as we discuss the CAPS-5 scale, the opportunities and benefits of using an electronic version to help standardize scale administration and scoring across clinical research, and the promising results to date. 2024-06-1121 minWCG Talks TrialsWCG Talks TrialsCreating Partnerships: Aligning Vendor Support for Success in Clinical ResearchIn the most recent episode of WCG Talks Trials, we are joined by three industry experts, Amy Thue and Shelby Ward from WCG, and Russell Lampman from Merck to discuss the topic of optimizing vendor support, and ultimately the success, of clinical trials.Listen in as we dive into feedback and perspectives from both the sponsor and vendor side of the table—for valuable take-aways and insights into how vendor support is best aligned across all stakeholders.2024-03-0620 minWCG Talks TrialsWCG Talks TrialsWCG's IRB Policy Change: Harmonizing Consent (Part 2)In Part 2 of this discussion, Currien MacDonald, MD, CIP Medical Chair Director for WCG's IRB, discusses new FDA regulations for waiver of consent with Kelly Fitzgerald, PhD, WCG's IRB Executive Chair and VP IBC Affairs. 2024-02-2708 minWCG Talks TrialsWCG Talks TrialsWCG's IRB Policy Change: Harmonizing Consent (Part 1)In Part 1 of this discussion, Currien MacDonald, MD, CIP Medical Chair Director for WCG's IRB, discusses a policy change that is going into effect for WCG IRB with Lindsay Abrahams, Regulatory Chair Director. Lindsay and Currien discuss the concise summary and its application to consent forms, especially for WCG.2024-02-2706 minThe Next Phase: Exploring Innovation in Clinical TrialsThe Next Phase: Exploring Innovation in Clinical TrialsTech Trends & Transformations: in Clinical Trials: A Conversation with WCGOur latest guest is Sandy Smith, Senior VP of Clinical Solutions and Strategic Partnerships at WCG, a company that connects sponsors, CROs, sites, and participants to deliver efficient, safe and impactful clinical research. In this conversation, Sandy shares insights into her background as an advanced practice nurse and how she landed 3 years ago at WCG where she leads Clinical Solutions and Strategic Partnership to solve some of the biggest challenges in research. In this talk, Sandy will touch on her role connecting diverse stakeholders (sites, sponsors, CROs), while advocating for the patient’s voice. She will emphasize the co...2024-01-1724 minWCG Talks TrialsWCG Talks TrialsThe Ethical and Safety Considerations of Accelerating Oncology TrialsIn this episode of WCG Talks Trials, our expert panel discusses various ethical, safety, and logistical challenges in accelerating clinical trials for gene and cell therapies in oncology. The conversation explores the role of Institutional Review Boards (IRBs), Institutional Biosafety Committees (IBCs), Endpoint Adjudication Committees (EACs), and Data Monitoring Committees (DMCs) in overseeing these trials, addressing issues such as patient safety, complex trial designs, and emerging biosafety concerns. Our panelists emphasize the importance of transparent communication and collaboration between IRBs and IBCs, highlighting the need to balance the urgency of advancing research with ethical considerations. Additionally, the podcast explores...2024-01-1643 minWCG Talks TrialsWCG Talks TrialsEmbarking on a Research Revolution – A Conversation with Florence HealthcareIn episode 10 of WCG Talks Trials, we are joined by Catherine Gregor, the Chief Clinical Trial Officer at Florence Healthcare, to discuss Florence’s recent Research Revolution event and the importance of site enablement in clinical research. Listen in as we recap Research Revolution, share insights on emerging clinical trial trends and innovations, and have a candid conversation about what stands in the way of successful site enablement in clinical research. 2023-12-1830 minWCG Talks TrialsWCG Talks TrialsThe CRA’s Evolving Role in a Postpandemic IndustryIn this episode of WCG Talks Trials, we are joined by Elizabeth Weeks-Rowe, CCRA, author of The CRA’s Guide to Monitoring Clinical Research, 6th Edition.Led by WCG Director of Publications and Content, Leslie Ramsey, the discussion will delve into the ways the clinical trials industry has become more complex and technologically focused and the challenges clinical research associates (CRAs) face as monitors of clinical trials.Host: Leslie Ramsey, Director of Publications and Content, WCG  Participant: Elizabeth Weeks-Rowe, Independent Clinical Research Consultant2023-12-1436 minWCG Talks TrialsWCG Talks TrialsMAGI@home: Practical Intelligence, Real-life Examples, Actionable InformationIn this episode of WCG Talks Trials, we are joined by MAGI@home Steering Committee members, Jennifer Peterson, Director, Head of Clinical Quality at M3 Wake Research, and Geoffrey Schick, Director, Strategic Site Partnerships at WCG. Led by Carmin Gade, Chief Marketing Officer at WCG, the discussion will delve into the insights and value MAGI events provide that enable attendees to achieve success in their roles and professional development.2023-12-0429 minWCG Talks TrialsWCG Talks TrialsDiversity & Inclusion with Technology in Decentralized TrialsThis episode of WCG Talks Trials, hosted by Kelly Fitzgerald, Executive IRB Chair and Vice President of IBC Affairs at WCG, dives into the topic of diversity and inclusion with technology in decentralized clinical trials (DCTs). The episode explores the transformative opportunities that DCTs present for addressing diversity gaps in clinical research. The discussion features a panel of experts, including Otis Johnson, former Chief Diversity, Inclusion, and Sustainability Officer at Clario; Archana Sah, a seasoned clinical development leader with a focus on oncology and healthcare technology; and Ken McCann, a physician with a background in pediatrics and a keen...2023-11-221h 05WCG Talks TrialsWCG Talks TrialsAmplifying Patient Voices to Advance Clinical Research: The Importance of Patient AdvocacyListen to the latest episode of WCG Talks Trials to hear from experts on the importance of patient advocacy in clinical research and key takeaways from WCG's 2023 Patient Forum. We'll summarize how the patient forum elevates the voices of those changing drug development for the better and recap breakthroughs and best practices shared during the most recent event.Discover more about patient and researcher collaboration, expanding diversity, equity, and inclusion in trials, and the latest advocacy-driven technology, science, and policy breakthroughs leading to modernized clinical research.  Guests:Desiree Underwood-Williams, PMP, CLSSBB, Director, P...2023-11-1329 minmove Podcastmove Podcast22. Knut Paulsen, Partner bei Welke Consulting Group (WCG)In der heutigen Folge haben wir Knut Paulsen, Partner bei Welke Consulting Group (WCG) in unserem Podcast zu Gast. Knut hat sich - anders als viele Berater - gegen einen akademischen Werdegang entschieden und war lange in der Eventmanagement und Lebensmittel Branche tätig, bevor es ihn 2010 zu der WCG verschlagen hat. Gemeinsam sprechen wir über seinen Werdegang, was für Ihn "Arbeit mit Verantwortung" bedeutet und welchen Rat er jungen Menschen mit auf den Weg geben würde.   WCG ist eine mittelständische Beratung mit Sitz in Siegen, Freudenberg und Hamburg. Gemeinsam mit ihren Kunden...2023-11-101h 33WCG Talks TrialsWCG Talks TrialsThe Importance of Diversity, Equity, Inclusion, and Intersectionality in Clinical ResearchListen to the latest episode of WCG Talks Trials to hear from experts on the importance of diversity, equity, and inclusion in clinical research and how intersectionality plays a role in promoting DE&I. We'll discuss why diversity is pivotal for comprehending the full spectrum of clinical care mechanisms and review effective DE&I strategies being deployed today. Discover how communities can be more actively engaged in clinical research and hear real-world examples of success stories in promoting diversity, equity, and inclusion within clinical research.Moderator:Scott J. Hunter, PhD - Senior Scientific Expert, Neurodevelopmental and...2023-10-2736 minFantastic Universes PodcastFantastic Universes PodcastEpisode 74a | Fantastic Plays and Host WCG ExpandedAdam and Fantastic Universes staff writer Connor McIndewar begin their segment talking the joys of paper and digital card gaming. Host is the ambitious new British WCG. After the team's positive feedback on our first show profiling their game, Adam and Connor had a lot to rethink and some nice messages to say back! Host WCG Website: host-wcg.co.uk Weiss and Chill's YouTube Channel: https://www.youtube.com/@WeissAndChill The Original Episode: https://soundcloud.com/steve-ray-7/episode-74-fantastic-plays-talks-host-wcg Fantastic Universes: www.fantasticuniverses.com Fantastic Universes' Twitter: @FANuniverses Adam's Linktree: linktr.ee/izzettinkerer Connor's Twitter: twitter.com/Akhariou?s=20 Intro...2023-10-1113 minFantastic Universes PodcastFantastic Universes PodcastEpisode 74 | Fantastic Plays Talks Host WCGAdam and Fantastic Universes staff writer Connor McIndewar begin their segment talking the joys of paper and digital card gaming. Host is the ambitious new British WCG. The new genre of Warring Card Game has our hosts eager to understand everything about this home grown slice of competitive collectible card gaming. Host WCG Website: https://host-wcg.co.uk/index.php Fantastic Universes: www.fantasticuniverses.com Fantastic Universes' Twitter: @FANuniverses Adam's Linktree: linktr.ee/izzettinkerer Connor's Twitter: twitter.com/Akhariou?s=20 Intro and Outro Music: 'The Attic' by Professor Elemental and Tom Caruana2023-10-0934 minWCG Talks TrialsWCG Talks TrialsDelve into the World of Psychedelic Research and Ethical InquiryJoin WCG Talks Trials podcast host Kelly Fitzgerald, PhD, in a riveting dialogue with guest expert Currien MacDonald, MD, as they unravel the nuances of "Psychedelics in Research: Ethical and Medical Perspectives." Dr. MacDonald, with a solid foundation in family medicine and clinical trials administration, guides listeners through a grounded exploration of psychedelic substances. In this episode, they demystify the realm of psychedelics, encompassing both dissociative and classic varieties, such as LSD and MDMA. As the conversation delves into ongoing research, the potential applications of these compounds in treating mental health challenges like depression, anxiety, an...2023-09-2625 minWCG Talks TrialsWCG Talks TrialsA 360-degree View on Motivators and Deterrents to Clinical Trial ParticipationIn episode three of WCG Talks Trials, two WCG experts discuss key findings from the 2023 Avoca State of the Industry Report, which provides a 360-degree view on motivators and deterrents to clinical trial participation.Listen in as we dive into feedback from perspectives across all clinical research stakeholders — sponsors, providers, sites, and patients — for valuable take-aways and insights into the trial experience.Speakers:Crissy MacDonald, PhD, Vice President, Client Delivery, WCG AvocaGina DiCindio, Associate Director, Industry and Client Research, WCG Avoca2023-09-1130 minWCG Talks TrialsWCG Talks TrialsBreaking Down Enrollment Barriers: How DE&I, Technology, and Protocol Design Impact Enrollment SuccessIn episode two of WCG Talks Trials, we are joined by two WCG experts to discuss overcoming common enrollment challenges and how DE&I, technology, and protocol design factor into enrollment success.Listen in as we delve into the critical topic of common enrollment barriers in clinical trials, how to improve enrollment by focusing on DE&I efforts, the importance of site-centric and patient-centric technologies, and how thoughtful protocol design plays a significant role in enrollment success.Speakers:Dawn Sauro, Chief Growth Officer, WCGJamie Harper, MHA, CCRP - Vice President, Site Solutions...2023-08-1618 minWCG Talks TrialsWCG Talks TrialsUnlocking Site Potential: Reducing Site Burden and Enhancing Clinical Trial EfficiencyIn the first episode of our new podcast series, WCG Talks Trials, we are joined by three industry experts, Lisa Ballance from Virginia Commonwealth University, John Musser from Florida Cancer Specialists and Research Institute, and Dan Otap from Genentech, to discuss the topic of overcoming site challenges and addressing site burden.Listen in as we discuss the results of WCG’s recently published 2023 Clinical Research Site Challenges Survey Report, gain insights from our guests on solutions their organizations have implemented to reduce site burden, and share perspectives on how sites, sponsors, and CROs can work to improve si...2023-07-1635 minWCG BizcastWCG BizcastCRNA: Tax Deductions | WCG Inc. | BizcastJason Watson, CPA, Joseph Bassett, EA, and Megan Oeltjenbruns, CPA, run through the common tax deductions that a CRNA can use as a 1099 contractor. What can be a business deduction and the rules that apply to getting that deduction. Related Blog Posts: https://wcginc.com/kb/home-office-deduction/ https://wcginc.com/kb/tax-free-rental-of-your-home/ https://wcginc.com/kb/automobiles-and-llcs-s-corps/ https://wcginc.com/business-services/s-corp-salary/ Visit WCG today at: https://wcginc.com/ --- Find us Online! ► Facebook: https://www.facebook.com/WCGIncCPA/ ► LinkedIn: https://www.linkedin.com/company/wcginc ► Twitter: https://twitter.com/wcginccpa ► Instagram: https://www.instagram.com/wcginccpa/2022-10-1726 minWCG BizcastWCG BizcastCRNA: State Issues | WCG Inc. | BizcastJason Watson, CPA, Joseph Bassett, EA, and Megan Oeltjenbruns, CPA, continue their discussion on the CRNA industry. How doing business differs depending on the state you have your business registered in and where you do your business. The impact a state could have on your income taxes and payroll processing too. Visit WCG today at: https://wcginc.com/ --- Find us Online! ► Facebook: https://www.facebook.com/WCGIncCPA/ ► LinkedIn: https://www.linkedin.com/company/wcginc ► Twitter: https://twitter.com/wcginccpa ► Instagram: https://www.instagram.com/wcginccpa/2022-10-1719 minWCG BizcastWCG BizcastCRNA: W-2 and 1099 | WCG Inc. | BizcastJason Watson, CPA, Joseph Bassett, EA, and Megan Oeltjenbruns, CPA, discuss who a CRNA is and their industry. They break down the differences between a CRNA being a 1099 contractor or a W-2 employee and which gives a CRNA more money and more deductions. Related Blog Post: https://wcginc.com/business-formation-services/s-corp-election/ Visit WCG today at: https://wcginc.com/ --- Find us Online! ► Facebook: https://www.facebook.com/WCGIncCPA/ ► LinkedIn: https://www.linkedin.com/company/wcginc ► Twitter: https://twitter.com/wcginccpa ► Instagram: https://www.instagram.com/wcginccpa/2022-10-1708 minWCG BizcastWCG BizcastCRNA: Business Entity Matters | WCG Inc. | BizcastJason Watson, CPA, Joseph Bassett, EA, and Megan Oeltjenbruns, CPA, talk about the type of business entity a CRNA should be set up as and why some states are easier than others to set up your business. The benefits of the S-Election.Why you could be wearing two hats now and how the election factors into your income. Related Blog Post: https://wcginc.com/kb/basic-business-entities/ Visit WCG today at: https://wcginc.com/ --- Find us Online! ► Facebook: https://www.facebook.com/WCGIncCPA/ ► LinkedIn: https://www.linkedin.com/company/wcginc ► Twitter: https://twitter.com/wcginccpa ► Instagram: https://www.instagram.com/wcginccp2022-10-1712 minWCG BizcastWCG BizcastOur Ideal Client RelationshipsJason Watson, CPA, Jason Schneider, CPA, and Megan Oeltjenbruns, CPA, wrap up our series of bizcasts discussing WCG and what we have to offer those looking to join our team. They discuss the type of client engagements we are seeking as a firm. Visit WCG today at: https://wcginc.com/ --- Find us Online! ► Facebook: https://www.facebook.com/WCGIncCPA/ ► LinkedIn: https://www.linkedin.com/company/wcginc ► Twitter: https://twitter.com/wcginccpa ► Instagram: https://www.instagram.com/wcginccpa/2021-07-1520 minWCG BizcastWCG BizcastCulture at WCGJason Watson, CPA, Jason Schneider, CPA, and Megan Oeltjenbruns, CPA, discuss the culture at WCG for prospective employees looking for a new work family. Visit WCG today at: https://wcginc.com/ --- Find us Online! ► Facebook: https://www.facebook.com/WCGIncCPA/ ► LinkedIn: https://www.linkedin.com/company/wcginc ► Twitter: https://twitter.com/wcginccpa ► Instagram: https://www.instagram.com/wcginccpa/2021-07-1517 minWCG BizcastWCG BizcastChallenges at WCGJason Watson, CPA, Jason Schneider, CPA, and Megan Oeltjenbruns, CPA, discuss the challenges of our firm faces, internally and systemically, and why we are excited about them. Visit WCG today at: https://wcginc.com/ --- Find us Online! ► Facebook: https://www.facebook.com/WCGIncCPA/ ► LinkedIn: https://www.linkedin.com/company/wcginc ► Twitter: https://twitter.com/wcginccpa ► Instagram: https://www.instagram.com/wcginccpa/2021-07-1517 minWCG BizcastWCG BizcastHow to be Successful at WCGJason Watson, CPA, Jason Schneider, CPA, and Megan Oeltjenbruns, CPA, discuss what it takes to be successful at WCG and the positions that we are seeking to fill. Visit WCG today at: https://wcginc.com/ --- Find us Online! ► Facebook: https://www.facebook.com/WCGIncCPA/ ► LinkedIn: https://www.linkedin.com/company/wcginc ► Twitter: https://twitter.com/wcginccpa ► Instagram: https://www.instagram.com/wcginccpa/2021-07-1515 minWCG BizcastWCG BizcastLife and Leadership at WCGJason Watson, CPA, Jason Schneider, CPA and Megan Oeltjenbruns, CPA, discuss life at WCG. The leadership WCG is looking for and how two of our newest leaders have adapted to the merging of two CPA firms in the last year. Visit WCG today at: https://wcginc.com/ --- Find us Online! ► Facebook: https://www.facebook.com/WCGIncCPA/ ► LinkedIn: https://www.linkedin.com/company/wcginc ► Twitter: https://twitter.com/wcginccpa ► Instagram: https://www.instagram.com/wcginccpa/2021-07-1517 minWCG Talks TrialsWCG Talks TrialsLisa LaLuna, Matchmaking to Save Lives: The Clinical Trial Search Tool for EveryoneFrom a career devoted to finding better ways to connect patient volunteers to clinical trials, Lisa LaLuna knows why the public needed an online search tool that is easier to use than the traditional methods of access. “Members of the public often want to find a trial to access the latest medicine, or help a family member, or just to participate as a healthy volunteer to further medical research.  Pharmaceutical companies that run clinical trials of course want to enroll patients so their research can be successful.  In spite of this mutual desire to work together, patients and...2021-01-0809 minWCG Talks TrialsWCG Talks TrialsOn the Future of Movement Disorder Trials: Part 4 of WCG’s Transforming CNS Trials SeriesMovement disorder trials have always been demanding. Now, sponsors face an additional challenge: How do you ensure data integrity in the era of remote clinical trials? In this podcast, Bob Dagher, MD, WCG MedAvante-ProPhase’s Chief Medical Officer, addresses this in conversation with Steve Smith, WCG President of Patient Advocacy. This is the fourth episode in our series, “Transforming CNS Trials During COVID-19—and Beyond.”Sponsors planning to restart movement disorder programs need to be clear-eyed and realistic, Dagher counsels. “When it comes to remote assessments, we have to be vigilant and aware of what we can do and als...2020-10-2109 minWCG Talks TrialsWCG Talks TrialsOn the Future of Depression Trials: Part 3 of WCG’s Transforming CNS Trials SeriesIn major depressive disorder, researchers have used remote assessments for decades. As a result, many of these studies have had an easier time adapting to the new clinical trial landscape. But that doesn’t mean they are pandemic-proof. So what are the critical success factors for clinical depression programs—especially now?  In his conversation with WCG President of Patient Advocacy Steve Smith, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase offers his insights on the future of clinical depression trials. This is the third episode in our podcast series, “Transforming CNS Trials During COVID-1...2020-09-3010 minWCG Talks TrialsWCG Talks TrialsOn the Future of Schizophrenia Trials: Part 2 of WCG’s Transforming CNS Trials SeriesRemote assessments have become a necessity across CNS trials, but some areas are more complicated than others. Schizophrenia provides one such example; the risk of variability is high, and sponsors are concerned. In this podcast, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase, sits down with WCG President of Patient Advocacy Steve Smith to discuss the topic. This is the second episode in our podcast series, “Transforming CNS Trials During COVID-19—and Beyond.”PANSS—the gold standard rating scale for schizophrenia primary outcomes—is based largely on face-to-face interviews; it wasn’t developed for remote assessments...2020-09-2110 minWCG Talks TrialsWCG Talks TrialsThe Case for Centralized Monitoring: Optimizing Data Quality and Risk Management with Linda Sullivan and Steve YoungHow can CROs and sponsors detect potential problems and issues in clinical trial conduct and data quality? That’s one of the critical issues discussed in Steve Young’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Young, Chief Scientific Officer at CluePoint, discusses how risk-based quality management (RBQM) methodology, data analytics, and data surveillance are being utilized today to go beyond just ferreting out fraud.  Now, Young says, clinical trial stakeholders are deploying advanced statistical engines to detect quality and data breaches in investigational studies. According to Young, while there are still instanc...2020-08-3136 minWCG Talks TrialsWCG Talks TrialsStriving for Reliability: Optimizing Patient Report Data through World-Class Design Management with Linda Sullivan, Nat Katz, and Art MoralesCan patients be trained to report their symptoms more accurately? That’s one of the key topics discussed in Nat Katz’s and Art Morales’ interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Katz, the Chief Science Officer of WCG-Analgesic Solutions and Morales, Vice President, Technology Solutions at WCG, assert that, with proper design and implementation, you can structure clinical trials, such as pain management studies, so that patients learn how to better report their symptoms. With proper training, patients learn to accurately report their symptoms, resulting in more reliable...2020-08-2738 minWCG Talks TrialsWCG Talks TrialsThe Upside of Centralized Monitoring During a Pandemic: Linda Sullivan, Duncan Hall, and Rachel Oakley on Optimizing Clinical Trials through Innovative RBQM TechnologyHow are clinical trial companies pivoting to implement Risk-Based Quality Management programs during the pandemic? That’s one of the deep dives explored in Duncan Hall’s and Rachel Oakley’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Hall, founder and CEO of Triumph Research Intelligence (TRI) and Oakley, Vice President of RBQM Services at TRI, note that, when the COVID-19 pandemic first hit, CROs and sites performed risk assessments on their existing studies. Then those organizations took advantage of innovative technology that had a key tool for optimizing clinical trials —...2020-08-1941 minWCG Talks TrialsWCG Talks TrialsGet Rid of Those Silos: Linda Sullivan, Artem Andrianov, and Johann Proeve on How To Optimize Clinical Trials through RBQMWhat’s the secret to success for implementing a world-class holistic approach to a Risk-Based Quality Management (RBQM) system? That’s one of the key topics from Artem Andrianov‘s and Johanna Proeve’s interview with Executive Director of WCG’s Metric Champion Consortium (MCC), Linda Sullivan, MBA. Andrianov, CEO, and Proeve, Chief Science Officer at Cyntegrity emphasize the importance of developing a clinical trial platform that enables your organization to manage the entire quality management cycle rather than continuing with traditional silo-based approaches. This comprehensive approach, they explain, enables pharmaceutical companies to become more efficient in reducing r...2020-08-1742 minWCG Talks TrialsWCG Talks TrialsTurning Insights Into Action: Linda Sullivan and Ken Getz on How Metrics and Benchmarking Provide a Path To Optimizing Clinical Trials"What impact does a remote clinical team operating model have on clinical trial performance?" That’s one of the hot topics from Ken Getz’s interview with Executive Director of WCG’s Metric Champion Consortium (MCC), Linda Sullivan, MBA. He describes several projects that the Tufts Center for the Study of Drug Development (Tufts CSDD) is currently working on; ones that will provide robust, data-driven analysis and strategic insights that help drug development professionals improve pharmaceutical R&D. Getz is the Deputy Director of Tufts CSDD and Professor at the Tufts University School of Medicine. At any given t...2020-07-2934 minWCG Talks TrialsWCG Talks TrialsNow Is the Time: Making Your Clinical Trial More ResilientIn this episode, host Linda Sullivan, MBA, Executive Director of WCG's Metric Champion Consortium (MCC) chats with Laurie Halloran, founder of the Halloran Consulting Group, about how she developed an on-demand drug development team that can fill in gaps in the clinical trial process for life science companies, whether these involve regulatory strategy or execution, or quality, clinical, or manufacturing issues. The COVID-19 pandemic has resulted in these companies having to pivot to more virtual experiences. At the beginning of the outbreak, she notes, her group organized town halls that made it clear to stakeholders that life science companies...2020-07-2432 minMore Than Marketing PodcastMore Than Marketing Podcast018: 4 Reasons Why Your Website Isn’t EffectiveOn this episode of More Than Marketing…Rob talks about four ways that your website could be missing out on great traffic and getting noticed locally.—Podcast BioMore Than Marketing is a podcast that tells the story of businesses. From startups to Fortune 500, we detail how companies plan and execute—and why a company needs to be “more than marketing” to be successful.The undercurrent of this podcast is the story of Wayne Consulting Group. A marketing, advertising, and organizational development firm based in Howell, MI and Louisville, KY. Severa...2020-06-1524 minWCG Talks TrialsWCG Talks TrialsChristopher Gantz, Building Trust and minority enrollment in clinical trials at Thomas Jefferson Hospital in Philadelphia“Our research population should match our community population.” That’s one of the takeaways from Christopher Gantz’s interview with WCG President of Patient Advocacy Steve Smith. He describes several programs that help connect researchers with minority communities to increase engagement and access enrollment in clinical trials. Gantz is senior director of the Regional Liaison Office at the Sidney Kimmel Cancer Center (SKCC) at Thomas Jefferson Hospital in Philadelphia. Since 2005, he has worked on multiple clinical trials projects with recruitment goals ranging from 500 to 10,000 participants. He describes establishing an “honest broker network” and engagement of resources within the hospital...2020-06-1221 minWCG Talks TrialsWCG Talks TrialsPeople, Process and Technology: The Right Combination for Successful Expert CommitteesIndependent expert committees provide essential validation of clinical data. Without their insights, sponsors risk missed signals, conflicts of interest and costly delays. But establishing a successful expert committee can be tricky. It requires the right combination of people, process and technology. In this three-part podcast, Lakshmi Sundar, head of business transformation at WCG ACI Clinical, explores each of these with a WCG ACI expert.In the first part of the series, Bill Stedman, manager of member services, shares his perspective on the “people” aspect. He discusses how success rests on having the right combination of expertise. Then, Dr...2020-06-0344 minMore Than Marketing PodcastMore Than Marketing Podcast017: Small Business COVID RecoveryOn this episode of More Than Marketing…Rob talks about the ongoings on the business since COVID hit and also how small businesses can recover from COVID and move forward.—Podcast BioMore Than Marketing is a podcast that tells the story of businesses. From startups to Fortune 500, we detail how companies plan and execute—and why a company needs to be “more than marketing” to be successful.The undercurrent of this podcast is the story of Wayne Consulting Group. A marketing, advertising, and organizational development firm based in Howell, MI...2020-06-0114 minWCG Talks TrialsWCG Talks TrialsFrank Sasinowski, MS, MPH, JD Hymen Phelps & McNamara: Rare Disease Regulatory Transformation: 1983 AIDS Crisis to PresentDrug policy has transformed to bring transformative improvement to the way rare diseases are developed resulting in more FDA approved treatments.This transformation came about because of collaboration across stakeholders: patient advocates, the FDA, Congress, drug developers, researchers, and legal specialists.  Profound change came in the mid 1980’s when AIDS activists, Rare Disease Activists, and others found ways to use policy to accelerate development of FDA approved treatments.Legal specialists Frank Sasinowski of Hymen Phelps and McNamara has always been a champion of the patient voice in legislative change, drug development policy, and FDA approvals.2020-04-2837 minMore Than Marketing PodcastMore Than Marketing Podcast015: April 24, 2020 State of The WCGOn this episode of More Than Marketing…Rob Johnson talks about what’s been going on with the WCG since COVID-19 hit. He also gives some updates on Speakeasy Podcast Network and Wayne Media Group.—Podcast BioMore Than Marketing is a podcast that tells the story of businesses. From startups to Fortune 500, we detail how companies plan and execute—and why a company needs to be “more than marketing” to be successful.The undercurrent of this podcast is the story of Wayne Consulting Group. A marketing, advertising, and organization...2020-04-2410 minMore Than Marketing PodcastMore Than Marketing Podcast014: Experience Edge VentureOn this episode of More Than Marketing…Rob Johnson talks to the leaders of Edge Venture Ministries. They go in-depth about the ministry and how it’s impacting families across the country.—Podcast BioMore Than Marketing is a podcast that tells the story of businesses. From startups to Fortune 500, we detail how companies plan and execute—and why a company needs to be “more than marketing” to be successful.The undercurrent of this podcast is the story of Wayne Consulting Group. A mar...2020-04-2416 minWCG Talks TrialsWCG Talks TrialsThomas Farrington: Cancer Survivor’s Prostate Health Network gets African American Communities Talking About Prostate CancerIn this podcast, Thomas Farrington, founder of the Prostate Health Network, speaks with WCG President of Patient Advocacy Steve Smith.Mr. Farrington discusses his experience with the healthcare system, coupled with his own research on prostate cancer, which led him to become a vocal advocate for prostate cancer patients and survivors. His advocacy spans a wide range of approaches from educational seminars, a frequently-visited website, a theater production called Daddy’s Boy that is now on tour, and visits to legislators on Capitol Hill to help shape public policy for the benefit of people with this unmet me...2020-04-2121 min